anmelden
Swiss All Share Index
18.523,94
PKT
-3,19
PKT
-0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.05.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 13.05.26 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 13.05.26 | UBS Buy | Deutsche Bank AG | |
| 13.05.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 12.05.26 | Richemont Outperform | Bernstein Research | |
| 12.05.26 | UBS Neutral | Goldman Sachs Group Inc. | |
| 12.05.26 | Richemont Overweight | Barclays Capital | |
| 11.05.26 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.05.26 | Holcim Overweight | JP Morgan Chase & Co. | |
| 11.05.26 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 08.05.26 | ams-OSRAM Buy | UBS AG | |
| 08.05.26 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 08.05.26 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 08.05.26 | Swiss Re Underperform | RBC Capital Markets | |
| 08.05.26 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 07.05.26 | Swiss Re Kaufen | DZ BANK | |
| 07.05.26 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 07.05.26 | Swiss Re Underweight | Barclays Capital | |
| 07.05.26 | UBS Outperform | RBC Capital Markets | |
| 07.05.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 07.05.26 | Swiss Re Underperform | RBC Capital Markets | |
| 07.05.26 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 06.05.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 05.05.26 | DocMorris Buy | Jefferies & Company Inc. | |
| 05.05.26 | ams-OSRAM Underweight | JP Morgan Chase & Co. | |
| 05.05.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | UBS Kaufen | DZ BANK | |
| 30.04.26 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 30.04.26 | UBS Buy | Deutsche Bank AG | |
| 30.04.26 | UBS Equal Weight | Barclays Capital | |
| 29.04.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.04.26 | Novartis Neutral | UBS AG | |
| 29.04.26 | UBS Equal Weight | Barclays Capital | |
| 29.04.26 | Novartis Buy | Deutsche Bank AG | |
| 29.04.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 29.04.26 | UBS Outperform | RBC Capital Markets | |
| 29.04.26 | Novartis Equal Weight | Barclays Capital | |
| 28.04.26 | Novartis Halten | DZ BANK | |
| 28.04.26 | Novartis Market-Perform | Bernstein Research | |
| 28.04.26 | Novartis Neutral | UBS AG |